1.210USD-0.82%Mkt Cap: 5.79M $P/E: —1d ago
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United State…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.74BUSDP/E 19.8
$20.14BUSD
$17.18BUSDP/E 26.3
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$7.11BUSDP/E 470.2
$7.00BUSDP/E 25.7
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.79BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.36BUSD
$1.90BUSDP/E 19.2
$1.97BUSD
$1.80BUSDP/E 20.3
$1.84BUSD
$1.74BUSD
$1.57BUSD
$1.48BUSDP/E 17.5
$1.52BUSDP/E 125.7
$1.35BUSDP/E 14.3
$1.21BUSDP/E 38.0
$1.17BUSDP/E 17.5
$1.16BUSD
$1.20BUSD
$1.07BUSDP/E Infinity
$1.01BUSD
$1.01BUSDP/E 197.0
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$870.61MUSDP/E 11.9
$819.46MUSDP/E Infinity
$664.05MUSD
$702.13MUSDP/E 163.7
$635.41MUSDP/E 6.2
$503.88MUSDP/E 14.2
$516.92MUSD
$463.93MUSD
$437.60MUSD
$393.68MUSD
$377.35MUSD
$359.47MUSD
$339.22MUSD
$337.13MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.26MUSDP/E 9.7
$290.59MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$246.73MUSDP/E 12.3
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$202.91MUSD
$197.15MUSD
$187.92MUSDP/E 9.0
$175.54MUSD
$166.91MUSD
$143.51MUSDP/E 18.3
$132.34MUSD
$141.87MUSD
$128.15MUSD
$119.66MUSDP/E 18.6
$102.48MUSD
$85.39MUSDP/E 12.3
$93.61MUSD
$72.08MUSD
$65.22MUSD
$68.77MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$64.05MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$41.74MUSD
$46.21MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.40MUSD
$24.18MUSD
$23.84MUSDP/E 206.0
$23.98MUSD
$23.08MUSD
$22.15MUSD
$18.78MUSD
$18.30MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$13.96MUSD
$11.82MUSD
$11.45MUSD
$9.96MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$5.98MUSDP/E 0.2
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$1.85MUSD
$1.85MUSDP/E 31.6
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap5.79M $
Enterprise Value4.28M $
Revenue (TTM)19.53M $
Gross Profit7.42M $
Net Income (TTM)-3.17M $
Revenue/Share11.60 USD
Last Price1.210 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.18
PEG1.08
EV/EBITDA-1.84
EV/Revenue0.22
P/S0.30
P/B0.71
EPS (TTM)-1.89
EPS (Forward)-0.56
52W Range
0.85006% of range6.920
52W High6.920 USD
52W Low0.8500 USD
Profitability
Gross Margin37.97%
Oper. Margin-6.31%
EBITDA Margin-11.89%
Profit Margin-16.26%
ROE-102.58%
ROA-22.74%
Growth
Revenue Growth48.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.93M $
CapEx (TTM)192.00K $
FCF Margin-15.99%
FCF Yield-53.92%
Net Debt-1.56M $
Net Debt/EBITDA0.67
Balance Sheet
Debt/Equity0.27
Current Ratio2.50
Quick Ratio1.04
Book Value/Sh1.720 USD
Cash/Share0.5010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 20, 2019
Splits
Last Split1:20
Split DateAug 30, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.79M
Float4.77M
Insiders0.42%
Institutions1.43%
Short Interest
Short Ratio0.5d
Short % Float1.73%
Short % Out.1.73%
Shares Short82.83K
Short (prev mo.)45.36K
Technical
SMA 501.158 (+4.5%)
SMA 2002.636 (-54.1%)
Beta1.27
S&P 52W Chg20.25%
Avg Vol (30d)108.29K
Avg Vol (10d)88.63K
Technical Indicators
RSI (14)50.0
MACD0.0103
MACD Signal0.0054
MACD Hist.+0.0049
BB Upper1.294 USD
BB Middle1.202 USD
BB Lower1.109 USD
BB Width15.40%
ATR (14)0.0686 USD
Vol Ratio (20d)0.81x